Investigational Site Number : 643001
Moscow 129128
2 studies enrolling now · 24 studies all time
What they study most
Acute Coronary Syndrome, Asthma, Cerebroside Lipidosis Syndrome, Colorectal Cancer Metastatic, Diabetes Mellitus, Type 2, Fabry Disease, Gaucher Disease, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Glycogen Storage Disease Type II (GSD II), Hematopoietic Neoplasm, Mucopolysaccharidosis I (MPS I)
Studies at this site
- Fabry Disease Registry & Pregnancy Sub-registry — Recruiting now
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry — Recruiting now
- Mucopolysaccharidosis I (MPS I) Registry — Completed
- Phase III Study of SAR302503 in Intermediate-2 and High Risk Patients With Myelofibrosis — Completed
- Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis — Completed
- Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH) — Completed
- Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease — Completed
- Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
- Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) — Completed
- Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
- Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen — Completed
- To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET) — Completed
- Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
- An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma — Completed
- To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN) — Completed
- To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA) — Completed
- To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis — Completed
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) — Completed
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
- Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain — Completed
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
- Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed
- Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery — Completed